Cargando…
QTc prolongation risk among patients receiving oral targeted antineoplastic medications: A real-world community-based oncology analysis
INTRODUCTION: Thirty oral targeted antineoplastic agents are associated with prolongation of the QT interval. However, limited data exists regarding QTc prolongation and associated risk factors in the ambulatory oncology setting. METHODS: This retrospective study was completed to describe QTc prolon...
Autores principales: | Reeves, David J., Russell, Molly, Rao, Vijay U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036778/ https://www.ncbi.nlm.nih.gov/pubmed/36969042 http://dx.doi.org/10.3389/fonc.2023.1098333 |
Ejemplares similares
-
QTc Prolongation in Patients Receiving Triazoles and Amiodarone
por: Cook, Katherine, et al.
Publicado: (2017) -
Real-world study of patients with locally advanced HNSCC in the community oncology setting
por: Black, Christopher M., et al.
Publicado: (2023) -
Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
por: Gupta, Anunay, et al.
Publicado: (2020) -
Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017) -
Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)